Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Koch
Marcus W
MW
Mostert
Jop P
JP
de Vries
Joeke J
JJ
De Keyser
Jacques
J
D001930:Brain Injuries / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D018450:Disease Progression; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*
D016899:Interferon-beta